LON:GNS Genus (GNS) Share Price, News & Analysis GBX 2,286.50 +46.51 (+2.08%) As of 10/23/2026 12:02 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsInsider TradesNews and Trends About Genus Stock (LON:GNS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Genus alerts:Sign Up Key Stats Today's Range 2,184▼ 2,28850-Day Range 2,074▼ 2,36052-Week Range 1,943▼ 3,220Volume6.18 million shsAverage Volume736,302 shsMarket Capitalization£1.51 billionP/E Ratio5.38Dividend Yield1.58%Price TargetGBX 3,216.67Consensus RatingBuy Company Overview Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. In addition, it offers technical services to farmers. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom. Read More Genus Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks74th Percentile Overall ScoreGNS MarketRank™: 3.69749026976 of 5 starsGenus scored higher than 74% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.7 / 5Analyst RatingBuy Consensus RatingGenus has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no strong buy ratings, 3 buy ratings, no hold ratings, and no sell ratings.Upside PotentialGenus has a consensus price target of GBX 3,216.67, representing about 40.7% upside from its current price of GBX 2,286.51.Amount of Analyst CoverageGenus has only been the subject of 1 research reports in the past 90 days.Read more about Genus' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Genus is 5.38, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.38.Price to Earnings Ratio vs. SectorThe P/E ratio of Genus is 5.38, which means that it is trading at a less expensive P/E ratio than the Consumer Discretionary sector average P/E ratio of about 45.23.Price to Earnings Growth RatioGenus has a PEG Ratio of 2.87. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioGenus has a P/B Ratio of 2.76. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for GNS. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldGenus pays a meaningful dividend of 1.58%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthGenus does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Genus is 7.74%. This payout ratio is at a healthy, sustainable level, below 75%.Read more about Genus' dividend. News and Social Media2.9 / 5News Sentiment0.72 News SentimentGenus has a news sentiment score of 0.72. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.42 average news sentiment score of Consumer Discretionary companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Genus this week, compared to 1 article on an average week.Search InterestOnly 2 people have searched for GNS on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days. Company Ownership1.4 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Genus insiders have sold more of their company's stock than they have bought. Specifically, they have bought GBX 0 in company stock and sold £1,080,576.36 in company stock.Percentage Held by Insiders0.71% of the stock of Genus is held by insiders.Percentage Held by Institutions54.86% of the stock of Genus is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Genus' insider trading history. Receive GNS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Genus and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GNS Stock News HeadlinesGenus (LON:GNS) Shares Cross Above Two Hundred Day Moving Average - Here's WhyOctober 21, 2026 | americanbankingnews.comGenus Cancels 188,000 Shares After Latest Buyback TrancheOctober 19, 2026 | tipranks.comWhy tech stocks are deadAI skeptics see dot-com era warning signs, and they have a point. But the real opportunity may not be in the big tech names pouring billions into data centers. Walmart's $24 million satellite network, AMR's Sabre system, and Capital One's 36,114 pricing tests all prove the same thing: compute has always been business's biggest moat, and it's about to get cheaper than ever. Porter Stansberry says one overlooked, government-protected sector is positioned to absorb this near-free compute boom and could become the next Magnificent 7.October 25 at 1:00 AM | Porter & Company (Ad)Genus plc Confirms Total Voting Rights and Share CapitalOctober 1, 2026 | tipranks.comGenus Issues New Shares to Employee Benefit Trust for Incentive PlansSeptember 30, 2026 | tipranks.comGenus Admits New Employee Scheme Shares to London MarketSeptember 28, 2026 | tipranks.comGenus Cancels 332,807 Shares After September BuybackSeptember 28, 2026 | tipranks.comGenus plc Cancels 238,464 Shares After September BuybackSeptember 21, 2026 | tipranks.comSee More Headlines GNS Stock Analysis - Frequently Asked Questions How have GNS shares performed this year? Genus' stock was trading at GBX 2,595 at the beginning of 2026. Since then, GNS shares have decreased by 11.9% and is now trading at GBX 2,286.51. How were Genus' earnings last quarter? Genus plc (LON:GNS) released its earnings results on Thursday, September, 10th. The company reported $110.30 earnings per share (EPS) for the quarter. Genus had a net margin of 43.35% and a trailing twelve-month return on equity of 44.90%. Read the conference call transcript. How do I buy shares of Genus? Shares of GNS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Genus own? Based on aggregate information from My MarketBeat watchlists, some other companies that Genus investors own include Advanced Micro Devices (AMD), Tesla (TSLA), Freeport-McMoRan (FCX), AstraZeneca (AZN), easyJet (EZJ), Glencore (GLEN) and GSK (GSK). Company Calendar Last Earnings9/10/2026Today10/25/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorConsumer Discretionary Industry Diversified Consumer Services Sub-IndustrySpecialized Consumer Services Current SymbolLON:GNS CIKN/A Webwww.genusplc.com Phone+44-1256-347100FaxN/AEmployees480Year FoundedN/APrice Target and Rating Average Price Target for GenusGBX 3,216.67 High Price TargetGBX 3,350 Low Price TargetGBX 3,000 Potential Upside/Downside+40.7%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)GBX 425.10 Trailing P/E Ratio5.38 Forward P/E Ratio32.22 P/E Growth2.87Net Income£7.87 million Net Margins43.35% Pretax MarginN/A Return on Equity44.90% Return on Assets3.31% Debt Debt-to-Equity Ratio14.02 Current Ratio2.22 Quick Ratio1.08 Sales & Book Value Annual Sales£658.10 million Price / Sales2.30 Cash FlowGBX 45.22 per share Price / Cash Flow50.56 Book ValueGBX 827.95 per share Price / Book2.76Miscellaneous Outstanding Shares66,152,000Free FloatN/AMarket Cap£1.51 billion OptionableNot Optionable Beta0.91 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (LON:GNS) was last updated on 10/23/2026 by MarketBeat.com Staff. From Our PartnersWhy tech stocks are deadAI skeptics see dot-com era warning signs, and they have a point. But the real opportunity may not be in the b...Porter & Company | Sponsored$0. Later: $29.97.Bill Poulos is giving away his Simple Options Trading For Beginners book through a temporary link. Once that l...Profits Run | SponsoredThe $100 Stock Behind Elon's Next MoveA small, publicly traded supplier trading under $100 a share has reportedly worked alongside Elon Musk for mor...Paradigm Press | SponsoredEarth's biggest energy source: near Grand CanyonThe largest energy source on Earth contains 50,000 times every oil and gas reserve on the planet combined - an...Behind the Markets | SponsoredHe turned $12K into $1.65M without touching Apple or TeslaTim Sykes turned $12,415 in gift money into more than $1.65 million before graduating college, without trading...Tim Sykes | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genus plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Genus With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.